Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/160546| Author(s): | Brito, C Resende, C Oliveira, P |
| Title: | A 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga |
| Publisher: | Springer |
| Issue Date: | 2016 |
| Abstract: | Introduction: Photodynamic therapy (PDT) is a well-established treatment for actinic keratosis (AK), basal cell carcinoma (BCC), and Bowen’s disease (BD). The object of this study was to describe the results of a retrospective analysis of patients treated with methyl aminolevulinate PDT (MAL-PDT) with red light, over the past decade at the Hospital de Braga (Braga, Portugal). Methods: This study is based on the retrospective analysis of the clinical records of patients treated with MAL-PDT from January 2003 to December 2013. Results: More than 550 patients with mean age of 72 years were treated with MAL-PDT. About two-thirds of these patients were female. In terms of diagnostics, 67% of the patient population were affected with AK, 27% presented with BCC, and 4% had BD. With an average follow-up of 5.5 years, 99.5% of the lesions had cleared. The recurrence of lesions occurred during the first year of follow-up, mostly large BCC localized on the trunk. Conclusion: This study showed the excellence of MAL-PDT for treating AK, BCC, and BD, with a low recurrence rate. © 2016, The Author(s). |
| DOI: | 10.1007/s13555-016-0116-7 |
| URI: | https://hdl.handle.net/10216/160546 |
| Source: | Dermatol Ther (Heidelb). 2016 Jun;6(2):265-72. doi: 10.1007/s13555-016-0116-7. Epub 2016 Apr 16. |
| Document Type: | Artigo em Revista Científica Internacional |
| Rights: | openAccess |
| License: | https://creativecommons.org/licenses/by/4.0/ |
| Appears in Collections: | ISPUP - Artigo em Revista Científica Internacional |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| brito2016.pdf | 786.25 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
